Literature DB >> 6970803

Bacteriology of acute otitis media unresponsive to initial antimicrobial therapy.

D W Teele, S I Pelton, J O Klein.   

Abstract

To determine the microbiology of acute otitis media unresponsive to initial antimicrobial therapy, we performed tympanocentesis on 43 children. All had failed to improve after at least 36 hours of therapy. Initial therapy was ampicillin or amoxicillin (31), trimethoprim-sulfamethoxazole (5), erythromycin and sulfisoxazole (5), erythromycin (1), and ampicillin and gentamicin (1). Among these children, 19% had isolates from middle ear fluid resistant to initial therapy. Bacteria sensitive to initial therapy were isolated from ten children (24%). The majority of children (57%) had bacteriologically negative middle ear fluid. Resistant isolates from children initially treated with ampicillin or amoxicillin were sensitive to trimethoprim-sulfamethoxazole or to erythromycin and sulfisoxazole, and vice versa. Critically ill children should have tympanocentesis to guide therapy; other children who fail to respond to antimicrobial therapy may receive alternative therapy as indicated by the results of this study.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6970803     DOI: 10.1016/s0022-3476(81)80755-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  14 in total

1.  Streptococcus pneumoniae: Activity of Newer Agents Against Penicillin-Resistant Strains.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

2.  The use of tympanocentesis in the diagnosis and management of acute otitis media.

Authors:  Michael E Pichichero; Tracy Wright
Journal:  Curr Infect Dis Rep       Date:  2006-05       Impact factor: 3.725

3.  Serum antibody response to three non-typeable Haemophilus influenzae outer membrane proteins during acute otitis media and nasopharyngeal colonization in otitis prone and non-otitis prone children.

Authors:  Ravinder Kaur; Janet R Casey; Michael E Pichichero
Journal:  Vaccine       Date:  2010-12-01       Impact factor: 3.641

4.  In vitro activity of antibiotics commonly used in the treatment of otitis media against Streptococcus pneumoniae isolates with different susceptibilities to penicillin.

Authors:  M M Tarpay; D F Welch; H Salari; M I Marks
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

5.  Effect of Streptococcus pneumoniae and influenza A virus on middle ear antimicrobial pharmacokinetics in experimental otitis media.

Authors:  G H Jossart; D M Canafax; G R Erdmann; M J Lovdahl; H Q Russlie; S K Juhn; G S Giebink
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

Review 6.  Importance of respiratory viruses in acute otitis media.

Authors:  Terho Heikkinen; Tasnee Chonmaitree
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

7.  An in vitro pharmacodynamic model to simulate antibiotic behavior of acute otitis media with effusion.

Authors:  K Vance-Bryan; T A Larson; M W Garrison; J P Toscano; D M Canafax; J C Rotschafer
Journal:  Pharm Res       Date:  1992-07       Impact factor: 4.200

8.  Upper respiratory tract infections. Ecological and therapeutic aspects of beta-lactamase production with special reference to Branhamella catarrhalis.

Authors:  I Eliasson; C Kamme
Journal:  Drugs       Date:  1986       Impact factor: 9.546

9.  Protection by serum antibodies in experimental nontypable Haemophilus influenzae otitis media.

Authors:  S J Barenkamp
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

10.  Acute otitis media in Sweden. Role of Branhamella catarrhalis and the rationale for choice of antimicrobial therapy.

Authors:  K Lundgren; L Ingvarsson
Journal:  Drugs       Date:  1986       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.